Boyle Scott N
C4 Therapeutics, Inc. · Chief Business Officer
Boyle Scott N is listed in filings as Chief Business Officer at C4 Therapeutics, Inc.. This profile follows SEC Form 4 activity through Feb 18, 2026, including sale activity. Recent filings connect the profile to C4 Therapeutics, Inc. (CCCC). The current snapshot covers public activity from Sep 17, 2024 to Feb 18, 2026. Reported amounts are shown as $13.7K to $2.1K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $2.1k669 shares | SellFeb 18, 2025 | $3.15 | $3.58 |